مرض الرئة الخلالي

إعداد فريق مايو كلينك
26 سبتمبر 2026

الأبحاث

تدرس عدة مختبرات بحثية في مايو كلينك أنماط أمراض الرئة لدى فئات مختلفة من الأشخاص، وتُجري تجارب سريرية تفحص الطرق الجديدة لعلاج أمراض الرئة، ومنها مرض الرئة الخلالي.

المنشورات

راجع قائمة المنشورات التي أعدّها أطباء مايو كلينك عن مرض الرئة الخلالي على محرك البحث PubMed، وهي خدمة تقدمها المكتبة الوطنية الأمريكية للطب.

  1. Ferri FF. Interstitial lung disease. In: Ferri's Clinical Advisor 2025. Elsevier; 2025. https://www.clinicalkey.com. Accessed Sept. 4, 2024.
  2. Lee, JS, et al. Overview of the management of adults with interstitial lung disease. https://www.uptodate.com/contents/search. Accessed Sept. 4, 2024.
  3. Mira-Avendano I, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clinic Proceedings. 2019; doi:10.1016/j.mayocp.2018.09.002.
  4. King TE Jr. Approach to the adult with interstitial lung disease: Clinical evaluation. https://www.uptodate.com/contents/search. Accessed Sept. 4, 2024.
  5. Maher, TM. Interstitial lung disease. JAMA. 2024; doi:10.1001/jama.2024.3669.
  6. King TE Jr. Approach to the adult with interstitial lung disease: Diagnostic testing. https://www.uptodate.com/contents/search. Accessed Sept. 4, 2024.
  7. Wijsenbeek MS, et al. Comprehensive supportive care for patients with fibrosing interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. 2019; doi:10.1164/rccm.201903-0614PP.
  8. Overview of interstitial lung disease. Merck Manual Professional Version. https://www.merckmanuals.com/professional/pulmonary-disorders/interstitial-lung-diseases/overview-of-interstitial-lung-disease. Accessed Sept. 4, 2024.
  9. George PM, et al. Progressive fibrosing interstitial lung disease: Clinical uncertainties, consensus recommendations, and research priorities. Lancet Respiratory Medicine. 2020; doi:10.1016/S2213-2600(20)30355-6.
  10. Goldman L, et al., eds. Interstitial lung disease. In: Goldman-Cecil Medicine. 27th ed. Elsevier; 2024. http://www.clinicalkey.com. Accessed Sept 4, 2024.
  11. Allscripts EPSi. Mayo Clinic.
  12. Pardo MC Jr., ed. Chronic pulmonary disease. In: Miller's Basics of Anesthesia. 8th ed. Elsevier; 2023. http://www.clinicalkey.com. Accessed Sept 4, 2024.
  13. What are interstitial lung diseases. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/interstitial-lung-diseases. Accessed Sept. 4, 2024.
  14. Wijsenbeek M, et al. Interstitial lung diseases. The Lancet. 2022; doi:10.1016/S0140-6736(22)01052-2.
  15. Podolanczuk AJ, et al. Update in interstitial lung disease 2020. American Journal of Respiratory and Critical Care Medicine. 2021; doi:10.1164/rccm.202103-0559UP.
  16. Rituxan (prescribing information). Genentech Inc.; 2024. https://www.rituxan.com/. Accessed Sept. 4, 2024.
  17. Ofev (prescribing information). Boehringer Ingelheim Pharmaceuticals Inc.; 2024. https://www.ofev.com/. Accessed Sept. 4, 2024.
  18. Esbriet (prescribing information). Genentech Inc.; 2024. https://www.esbriet.com/. Accessed Sept. 4, 2024.
  19. Treatment for GER and GERD. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/treatment. Accessed Sept. 4, 2024.
  20. Medical review (expert opinion). Mayo Clinic. Oct. 10, 2024.
  21. Portalatin GM, et al. Daptomycin-induced acute eosinophilic pneumonia. Cureus. 2021; doi:10.7759/cureus.13509.4
  22. Feldman D, et al. Bleomycin-induced lung injury. https://www.uptodate.com/contents/search. Accessed Sept. 6, 2024.
  23. Zhou X, et al. Intravesically instilled gemcitabine-induced lung injury in a patient with invasive urothelial carcinoma: A case report. World Journal of Clinical Cases. 2020; doi:10.12998/wjcc.v8i19.46524.
  24. Immunotherapy. American Cancer Society. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/immune-checkpoint-inhibitors.html. Accessed Sept. 6, 2024.